Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas.
about
A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinomaSurgical treatment for advanced pancreatic cancerPreoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data BasePrimary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the InterdisciplinaResectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer.Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiationThe role of radiotherapy in multimodal treatment of pancreatic carcinomaPancreatic adenocarcinomaA systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer.Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial.Radiologic and intraoperative detection of need for mesenteric vein resection in patients with adenocarcinoma of the head of the pancreasCurrent status of adjuvant therapy for pancreatic cancer.Comparison of 1-, 2-, and 3-Dimensional Tumor Response Assessment After Neoadjuvant GTX-RT in Borderline-Resectable Pancreatic Cancer.Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer.A novel approach to the intraoperative assessment of the uncinate margin of the pancreaticoduodenectomy specimen.Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis.Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.Neoadjuvant therapy in pancreatic cancer.Resection margins and R1 rates in pancreatic cancer--are we there yet?Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP).Multidisciplinary management of resectable adenocarcinoma of the pancreatic head.Redefining resection margin status in pancreatic cancerFriday, February 21, 2014, 5:00pm–6:30pm Oral Poster I (Liver I, II; Pancreas I, II; Biliary I; Transplant I; Other)Impact of preoperative therapy on patterns of recurrence in pancreatic cancerPreoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review.The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative TherapyThe concept of 'borderline resectable' pancreatic cancer: limited foundations and limited future?Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies.Neoadjuvant therapy for potentially resectable pancreatic cancer: an emerging paradigm?Advanced-stage pancreatic cancer: therapy options.Neoadjuvant therapy in patients with pancreatic cancer: a disappointing therapeutic approach?Pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma.Vascular resection during radical resection of pancreatic adenocarcinomas: evolution over the past 15 years.Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.Neoadjuvant Chemoradiotherapy and Surgery Versus Surgery Alone in Resectable Pancreatic Cancer: A Single-Center Prospective, Randomized, Controlled Trial Which Failed to Achieve Accrual Targets.Does radiologic response correlate to pathologic response in patients undergoing neoadjuvant therapy for borderline resectable pancreatic malignancy?Intensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer. Outcome analysis and comparison with a 3D-treated patient cohort.
P2860
Q26748880-72444EF4-462A-4B0E-9AA0-7CFE716F123DQ27003396-78858612-0156-42CD-8FB0-93EDD2FAE4E8Q30452636-D8661F8B-C9FA-4219-8DD8-3B29C8B59FC2Q30726275-CEACEFA2-A468-41A2-B4DD-2F5B343D29E0Q33276956-C4606ABA-2C27-49DB-93F8-ECFC918E44A1Q33314616-B413517C-655F-492E-B443-EB53E633BB07Q33408075-D030F591-4728-4E9E-93F9-6F3F9B5F49C1Q33928253-6AEF2188-0262-4F7C-B81D-CF96E3A7504BQ34025910-8760709A-490B-41D4-A6BB-A06C1A97DD8EQ34140498-7A9FD05A-1FA1-4091-AD42-A7FCEBBC11A3Q34632256-A035AA6D-CDE3-4A0B-8A4B-0579741DB83BQ34732306-E38C6EE3-B4E9-473C-B22A-6AAC667FB6E4Q34986932-199D3387-00A3-4821-972C-D85CC7E5B52DQ35244224-05775AF0-9DE3-4C8A-92D3-0A9C5858592DQ35583760-F7264AAD-CE7B-44BC-9BCA-E11F18CF8409Q35768026-DA622B27-1A5D-4965-996A-9826C01E3AC5Q35944817-E5863DFC-B1E8-4863-9E3C-84BA054600E0Q36063480-81ED29F6-8BA2-48EC-A3B0-46914C85D820Q36113317-3240A71F-FAB6-4FAC-ABAE-EC9E4F70AAFEQ36746016-CC89B843-26D1-4BFA-85BA-D13A5D27CBB9Q36871043-04D73727-5E0A-4B45-8671-97D9B9BAE843Q37032854-93B3C8BE-5317-4345-B3BE-2375100271C5Q37231106-0D53D88A-063E-44C5-8422-5746C1BDCEEDQ37300020-8EC19645-9B99-405F-B235-770C3ED0B098Q37305587-CAD95638-F80B-459D-B1CE-2F0E294936C0Q37480826-3B9764B9-C607-4EB9-9595-790F93E215C1Q37480832-3D23892C-EE4A-4278-AE22-DEC6B16918FEQ37510393-21F0CBC4-8BB6-4C94-9587-821538DD5492Q37539690-00E1C0D1-A3D5-4BAD-95D8-0DEEC723051EQ37677535-99380411-6338-435F-BBE5-DE64DD2513ADQ37947452-DBC785A0-9699-4EDD-BD02-420D8D73C3B8Q38074622-CFFDA446-094B-46C1-84AF-B5EAFDFD1983Q38102914-AB9EEEF2-FF96-4468-9E41-E4874C74F101Q38161359-79E347FF-218C-4EA8-B675-FFE1EA1B40D0Q38212152-54659279-B21D-4F6B-B659-E19278423AA2Q38217043-6ED18B08-E9AD-4B4F-B90A-B733F0D2ACAFQ38927638-E92EEB2E-1FA0-4006-9D18-7DF802E5CC55Q38979712-01A0E7A7-0B35-4E64-9B12-8A3055BD396DQ39010876-7B0FFDA1-78F3-4E15-8B89-9EE5D9269A4BQ39376002-61273B7F-EE0B-4171-B4BC-B4BCB014F688
P2860
Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Effect of preoperative chemora ...... a of the head of the pancreas.
@en
Effect of preoperative chemora ...... a of the head of the pancreas.
@nl
type
label
Effect of preoperative chemora ...... a of the head of the pancreas.
@en
Effect of preoperative chemora ...... a of the head of the pancreas.
@nl
prefLabel
Effect of preoperative chemora ...... a of the head of the pancreas.
@en
Effect of preoperative chemora ...... a of the head of the pancreas.
@nl
P2093
P921
P1476
Effect of preoperative chemora ...... a of the head of the pancreas.
@en
P2093
A R Sasson
B L Eisenberg
G Freedman
H S Cooper
J F Pingpank
J P Hoffman
N J Meropol
T E LeVoyer
W H Pinover
P304
P356
10.1016/S1091-255X(01)80023-8
P577
2001-03-01T00:00:00Z
P6179
1001216477